Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

Attention! Another new term has entered the TikTok lexicon, and you’re about to see it everywhere. If you’ve spent any time on the app within the past week, you might have noticed people talking about ...

Bengaluru: Meesho has pulled ahead of its consumer internet peers on free cash flow in FY25, underscoring a shift in India’s e-commerce sector from chasing growth to focusing on capital-efficient ...

Stock market graphs don’t have to be a mystery. Here’s how to read stock charts for any company. Many, or all, of the products featured on this page are from our advertising partners who compensate us ...

A recent study revealed that almost 90% of stock market traders experience financial losses during their trading journeys. This statistic highlights the challenges and inherent risks associated with ...

Andrew Kessel was a breaking news writer for Investopedia until October 2025. He previously covered markets for Proactive Investors, with a focus on small-cap stocks in fintech, healthcare, mining, ...

There comes a time before every big purchase when you might ask yourself, “Do I really need this?” If you don’t pause for a moment — and if you tend to blow your budget as a result — then you need to ...

Flowserve Corporation and Chart Industries, Inc. announced a merger of equals, aiming for diversification and $300 million in cost synergies, but investors reacted cautiously. Chart shareholders will ...

Chart Industries (NYSE:GTLS) and Flowserve (NYSE:FLS) said Wednesday they agreed to combine in an all-stock merger valued at ~$19B including debt, creating a differentiated leader in industrial ...